MARKET

CHFS

CHFS

CHF Solutions
NASDAQ

Real-time Quotes | Nasdaq Last Sale

0.3800
-0.0410
-9.74%
After Hours: 0.3893 +0.0093 +2.45% 17:54 04/07 EDT
OPEN
0.4060
PREV CLOSE
0.4210
HIGH
0.4100
LOW
0.3506
VOLUME
4.19M
TURNOVER
--
52 WEEK HIGH
4.600
52 WEEK LOW
0.3000
MARKET CAP
12.11M
P/E (TTM)
-0.0323
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 1 analysts

Strong Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average CHFS stock price target is 6.50 with a high estimate of 6.50 and a low estimate of 6.50.

EPS

CHFS News

More
  • CHF Solutions Doubles Production Staff of Aquadex SmartFlow Consoles Due to Hospital Demand
  • GlobeNewswire · 5d ago
  • CHF Solutions, Inc. Announces Pricing of Registered Direct Offering Priced At-the-Market
  • GlobeNewswire · 03/30 13:26
  • More Covid-19-related activity - healthcare
  • seekingalpha · 03/25 17:17
  • CHF Solutions Announces COVID-19 Patients Treated with Aquadex Therapy for Fluid Management
  • GlobeNewswire · 03/25 13:00

Industry

Advanced Medical Equipment & Technology
-1.01%
Healthcare Equipment & Supplies
-0.82%

Hot Stocks

Symbol
Price
%Change

About CHFS

CHF Solutions, Inc., formerly Sunshine Heart, Inc., is a medical device company. The Company is focused on commercializing the Aquadex FlexFlow System. The Aquadex FlexFlow System (Aquadex) is indicated for temporary (up to eight hours) ultrafiltration treatment of patients with fluid overload who have failed diuretic therapy. Aquadex is also indicated for extended (longer than 8 hours) ultrafiltration treatment of patients with fluid overloads who have failed diuretic therapy and require hospitalization.
More

Webull offers kinds of CHF Solutions Inc stock information, including NASDAQ:CHFS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CHFS stock news, and many more online research tools to help you make informed decisions.